Can Sitagliptin reduce microvascular complications in diabetes, such as nephropathy and retinopathy, through better long-term glycemic control?
Share
IVF Questions & Answers
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Can Sitagliptin reduce microvascular complications in diabetes, such as nephropathy and retinopathy, through better long-term glycemic control?
1. Sitagliptin may indirectly reduce microvascular complications like nephropathy and retinopathy by improving glycemic control, which is crucial in managing diabetes.
2. While Sitagliptin primarily manages blood glucose levels, consistent long-term use can lead to reduced risks of nephropathy and retinopathy by maintaining better glycemic control.
3. There is evidence suggesting that Sitagliptin, by ensuring better glycemic control over time, could potentially diminish the onset and progression of diabetes-related microvascular complications such as nephropathy and retinopathy.